Investor Presentaiton slide image

Investor Presentaiton

2022 H2 outlook: Hong Kong IPO market Global geopolitical, economic uncertainties and the ongoing pandemic, however, will continue to sully sentiment for the rest of the year in Hong Kong. Momentum is expected to pick up gradually as these uncertainties fade out, fuelled by the solid IPO pipeline as more than 170 applicants continue to wait to list on the city's bourse. In order to encourage the listing of specialist technology companies, authorities in Hong Kong are now reviewing the listing rules and considering whether to revise the listing requirements. More details on this matter are expected to be announced during the second half of the year. Despite the challenging funding environment and global market uncertainties, businesses across different sectors continue to purse major digital transformation and decarbonisation initiatives. Such demands are creating opportunities for companies involved in digital and sustainable/renewable technologies which would be attractive to strategic and corporate investors. " Homecoming and life science listings would remain the key focus, as Hong Kong continues to be the natural choice for homecoming listings, and with the relentless development for biotech fund-raising and investment ecosystem in the bourse. Irene Chu Partner Head of New Economy and Life Sciences KPMG China KPMG © 2022 KPMG, a Hong Kong (SAR) partnership and a member firm of the KPMG global organisation of independent member firms affiliated with KPMG International Limited, a private English company limited by guarantee. All rights reserved. Printed in Hong Kong (SAR). Mainland China and Hong Kong IPO markets 19
View entire presentation